TY - JOUR
T1 - Development and provider assessment of a new oncology network with care pathways for gastrointestinal cancer patients
T2 - the collaborative approach
AU - ten Haaft, Britte H. E. A.
AU - van Kessel, Eefje
AU - van Berge Henegouwen, Mark I.
AU - van den Bergh, Janneke E.
AU - Bolhuis, Karen
AU - Dohmen, Serge E.
AU - Erdmann, Joris I.
AU - van Geel, Anne M.
AU - Gerhards, Michael F.
AU - Gorris, Myrte
AU - Kager, Liesbeth M.
AU - Kodach, Liudmila L.
AU - Kok, Niels F. M.
AU - Koorstra, Jan-Bart M.
AU - Laeijendecker, Annelien E.
AU - van Sandick, Johanna W.
AU - Schreurs, Wilhelmina H.
AU - Sommeijer, Dirkje W.
AU - Swijnenburg, Rutger-Jan
AU - Tuynman, Jurriaan B.
AU - Verheij, Joanne
AU - Versteijne, Eva
AU - van der Velden, Ankie M. T.
AU - Voncken, Francine E. M.
AU - Wientjes, Caroline A.
AU - Wilmink, Johanna W.
AU - Zonderhuis, Barbara M.
AU - Kazemier, Geert
AU - Besselink, Marc G.
AU - OncoNoVo+ regional oncology network
AU - Zwezerijnen, Gerben
AU - van Zweeden, Annette
AU - Woensdregt, Karlijn
AU - Willemsen, Annelieke
AU - de Wijkerslooth, Thomas
AU - Weterman, Mariëtte
AU - Weijenborg, Pim
AU - van Wanrooij, Roy
AU - Walhout, Ingrid
AU - van Waesberghe, Jan Hein
AU - Vuylsteke, Ronald
AU - Vogten, Thijs
AU - Voermans, Rogier
AU - van der Vlugt, Manon
AU - Verwer, Bart
AU - Versteeg, Kathelijn
AU - van de Ven, Anthony
AU - Vehmeijer-Scherpenzeel, Amabel
AU - Veenhof, Alexander
AU - van Turenhout, Sietze
AU - Sterk, Andre
AU - Spoor, Sacha
AU - Spaan, Michelle
AU - Smit, Ruth
AU - Schrama, Jolanda
AU - Schoorlemmer, Annuska
AU - Schafrat, Pascale
AU - Rohof, Wout
AU - Rodjan, Firazia
AU - Rentinck, Marjolein
AU - Reimerink, Jorik
AU - Reigman, Henna
AU - van der Peet, Donald
AU - Oosterling, Steven
AU - Noteboom, Loes
AU - Nieuwenhuijzen, Jakko
AU - Musters, Gijsbert
AU - Mundt, Marco
AU - Meijer, Sybren
AU - Marsman, Hendrik
AU - Maas, Monique
AU - van Lent, Anja
AU - van Leerdam, Monique
AU - Lapid, Oren
AU - Lameris, Wytze
AU - Lambregts, Doenja
AU - Lahaye, Max
AU - van Laarhoven, Hanneke
AU - Kuijer, Philomeen
AU - Kuhlmann, Koert
AU - Klümpen, Heinz-Josef
AU - Klompenhouwer, Lisa
AU - Keijzer-Steur, Cynthia
AU - Jonker, Frederik
AU - Jansen, Edwin
AU - Huibregtse, Inge
AU - Horsthuis, Karin
AU - Hompes, Roel
AU - Hilhorst, Yvonne
AU - Hendriks, Mathijs
AU - Havenith, Simone
AU - Hartemink, Koen
AU - Grotenhuis, Brechtje
AU - Grootscholten, Cecile
AU - Govaert, Marc
AU - Gisbertz, Suzanne
AU - van Geloven, Nanette
AU - Geijsen, Debby
AU - Festen, Sebastiaan
AU - Sarasqueta, Arantza Farina
AU - Eshuis, Wietse
AU - Engelbrecht, Marc
AU - Dunker, Mich
AU - Drillenburg, Paul
AU - van Dieren, Jolanda
AU - Derks, Sarah
AU - Demirkiran, Ahmet
AU - van Delden, Otto
AU - Dekker, Evelien
AU - Debets, Saskia
AU - Corver, Maaike
AU - Conijn, Annemarie
AU - Chalabi, Myriam
AU - Cahen, Djuna
AU - Busch, Olivier
AU - Buffart, Tineke
AU - de Bruin, Gijs
AU - Bronk, Michelle
AU - Brandts, Freek
AU - Boparai, Karam
AU - Bloedjes, Mariska
AU - van Berkel, Anne-Marie
AU - Beets-Tan, Regina
AU - Beets, Geerard
AU - Beaumont, Hanneke
AU - Bastiaansen, Barbara
AU - Bartels-Rutten, Annemarieke
AU - Bakker, Sandra
AU - Bakker, Chris
AU - Andeweg, Caroline
AU - Allajar, Daud
AU - Aleman, Berthe
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12/1
Y1 - 2025/12/1
N2 - Background: In an era of increasing demands on healthcare services, the development of regional oncology networks including care pathways may be instrumental to improve the efficiency and quality of care. However, developing such networks involving numerous stakeholders and hospitals is challenging as no templates exist. This study evaluates the development of a large regional network with the objective to provide a practical template. Methods: A multicentre survey was conducted between October 1, 2024 and January 31, 2025. Clinicians from the departments of medical oncology, surgery, gastroenterology, pathology, radiology, nuclear medicine, and radiotherapy at the 13 hospitals in the OncoNoVo+ regional oncology network were invited. The survey included open-ended, multiple-choice, and slider questions (score range 0–100 on a visual analogue scale), focusing on baseline characteristics (n = 7), functioning of the network and care pathways (n = 16), and the development process of the care pathways (n = 6). Results: Overall, 216 medical specialists, researchers, nurse specialists, and case-managers from 13 hospitals developed six care pathways (esophagogastric, pancreatic, small intestinal, rectal, liver, and biliary tract cancer). In the survey, 135 (63%) clinicians participated. Median scores of 75 or higher were observed in nine out of 11 satisfaction statements. Highest scores were observed for statements about the importance of regional care pathways, the recommendation of pathways outside the region, and the effectiveness of the OncoNoVo+ app (median, 85 [IQR, 75 to 97], 85 [75 to 99], and 84 [75 to 95], respectively). Mentioned ‘essential factors for success’ included coordination, collaboration, technology, and mutual respect. ‘Improvement factors’ included clearer implementation, better communication, regular updates, and equal involvement across hospitals and specialties. Conclusion: The multicenter development and maintenance of regional care pathways for patients with gastrointestinal cancers within a regional oncology network seems feasible and effective with high satisfaction among participating hospitals. Implementation, communication, and equal involvement of centers and medical specialties deserve utmost attention.
AB - Background: In an era of increasing demands on healthcare services, the development of regional oncology networks including care pathways may be instrumental to improve the efficiency and quality of care. However, developing such networks involving numerous stakeholders and hospitals is challenging as no templates exist. This study evaluates the development of a large regional network with the objective to provide a practical template. Methods: A multicentre survey was conducted between October 1, 2024 and January 31, 2025. Clinicians from the departments of medical oncology, surgery, gastroenterology, pathology, radiology, nuclear medicine, and radiotherapy at the 13 hospitals in the OncoNoVo+ regional oncology network were invited. The survey included open-ended, multiple-choice, and slider questions (score range 0–100 on a visual analogue scale), focusing on baseline characteristics (n = 7), functioning of the network and care pathways (n = 16), and the development process of the care pathways (n = 6). Results: Overall, 216 medical specialists, researchers, nurse specialists, and case-managers from 13 hospitals developed six care pathways (esophagogastric, pancreatic, small intestinal, rectal, liver, and biliary tract cancer). In the survey, 135 (63%) clinicians participated. Median scores of 75 or higher were observed in nine out of 11 satisfaction statements. Highest scores were observed for statements about the importance of regional care pathways, the recommendation of pathways outside the region, and the effectiveness of the OncoNoVo+ app (median, 85 [IQR, 75 to 97], 85 [75 to 99], and 84 [75 to 95], respectively). Mentioned ‘essential factors for success’ included coordination, collaboration, technology, and mutual respect. ‘Improvement factors’ included clearer implementation, better communication, regular updates, and equal involvement across hospitals and specialties. Conclusion: The multicenter development and maintenance of regional care pathways for patients with gastrointestinal cancers within a regional oncology network seems feasible and effective with high satisfaction among participating hospitals. Implementation, communication, and equal involvement of centers and medical specialties deserve utmost attention.
KW - Cancer care pathways
KW - Gastrointestinal cancer
KW - Oncology networks
KW - Pathway development
KW - Regional collaboration
UR - https://www.scopus.com/pages/publications/105014996257
U2 - 10.1186/s12885-025-14710-y
DO - 10.1186/s12885-025-14710-y
M3 - Article
C2 - 40885947
SN - 1471-2407
VL - 25
JO - BMC cancer
JF - BMC cancer
IS - 1
M1 - 1402
ER -
SDG 3 Good Health and Well-being